Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer

被引:76
作者
Casey, G
Lindor, NM
Papadopoulos, N
Thibodeau, SN
Moskow, J
Steelman, S
Buzin, CH
Sommer, SS
Collins, CE
Butz, M
Aronson, M
Gallinger, S
Barker, MA
Young, JP
Jass, JR
Hopper, JL
Diep, A
Bapat, B
Salem, M
Seminara, D
Haile, R
机构
[1] Cleveland Clin, Lerner Coll Med, Dept Canc Biol, Cleveland, OH 44195 USA
[2] Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[4] GMP Genet, Waltham, MA USA
[5] City Hope Natl Med Ctr, Clin Mol Diagnost Lab, Duarte, CA 91010 USA
[6] Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada
[7] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada
[8] Bancroft Ctr, Cojoint Gastroenterol Lab, Herston, Qld, Australia
[9] McGill Univ, Dept Pathol, Montreal, PQ, Canada
[10] Univ Melbourne, Ctr Genet Epidemiol, Melbourne, Vic, Australia
[11] Univ So Calif, Norris Canc Ctr, Dept Prevent Med, Los Angeles, CA USA
[12] NCI, NIH, Bethesda, MD 20892 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 07期
关键词
D O I
10.1001/jama.293.7.799
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The accurate identification and interpretation of germline mutations in mismatch repair genes in colorectal cancer cases is critical for clinical management. Current data suggest that mismatch repair mutations are highly heterogeneous and that many mutations are not detected when conventional DNA sequencing alone is used. Objective To evaluate the potential of conversion analysis compared with DNA sequencing alone to detect heterogeneous germline mutations in MLH1, MSH2, and MSH6 in colorectal cancer patients. Design, Setting, and Participants Multicenter study with patients who participate in the Colon Cancer Family Registry. Mutation analyses were performed in participant samples determined to have a high probability of carrying mismatch repair germline mutations. Samples from a total of 64 hereditary nonpolyposis colorectal cancer cases, 8 hereditary nonpolyposis colorectal cancer-like cases, and 17 cases diagnosed prior to age 50 years were analyzed from June 2002 to June 2003. Main Outcome Measures Classification of family members as carriers or noncarriers of germline mutations in MLH1, MSH2, or MSH6; mutation data from conversion analysis compared with genomic DNA sequencing. Results Genomic DNA sequencing identified 28 likely deleterious exon mutations, 4 in-frame deletion mutations, 16 missense changes, and 22 putative splice site mutations. Conversion analysis identified all mutations detected by genomic DNA sequencing-plus an additional exon mutation, 12 large genomic deletions, and 1 exon duplication mutation-yielding an increase of 33% (14/42) in diagnostic yield of deleterious mutations. Conversion analysis also showed that 4 of 16 missense changes resulted in exon skipping in transcripts and that 17 of 22 putative splice site mutations affected splicing or mRNA transcript stability. Conversion analysis provided an increase of 56% (35/63) in the diagnostic yield of genetic testing compared with genomic DNA sequencing alone. Conclusions The data confirm the heterogeneity of mismatch repair mutations and reveal that many mutations in colorectal cancer cases would be missed using conventional genomic DNA sequencing alone. Conversion analysis substantially increases the diagnostic yield of genetic testing for mismatch repair mutations in patients diagnosed as having colorectal cancer.
引用
收藏
页码:799 / 809
页数:11
相关论文
共 20 条
  • [1] BAUDHUIN LM, IN PRESS J MOL DIAGN
  • [2] Boland CR, 1998, CANCER RES, V58, P5248
  • [3] 2002 William Allan Award Address - Inherited human diseases: Victories, challenges, disappointments
    de la Chapelle, A
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (02) : 236 - 240
  • [4] Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach
    Gille, JJP
    Hogervorst, FBL
    Pals, G
    Wijnen, JT
    van Schooten, RJ
    Dommering, CJ
    Meijer, GA
    Craanen, ME
    Nederlof, PM
    de Jong, D
    McElgunn, CJ
    Schouten, JP
    Menko, FH
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 892 - 897
  • [5] Clinical significance of early-onset "sporadic" colorectal cancer with microsatellite instability
    Jass, JR
    [J]. DISEASES OF THE COLON & RECTUM, 2003, 46 (10) : 1305 - 1309
  • [6] Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
    Lindor, NM
    Burgart, LJ
    Leontovich, O
    Goldberg, RM
    Cunningham, JM
    Sargent, DJ
    Walsh-Vockley, C
    Petersen, GM
    Walsh, MD
    Leggett, BA
    Young, JP
    Barker, MA
    Jass, JR
    Hopper, J
    Gallinger, S
    Bapat, B
    Redston, M
    Thibodeau, SN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 1043 - 1048
  • [7] GENETIC INSTABILITY OCCURS IN THE MAJORITY OF YOUNG-PATIENTS WITH COLORECTAL-CANCER
    LIU, B
    FARRINGTON, SM
    PETERSEN, GM
    HAMILTON, SR
    PARSONS, R
    PAPADOPOULOS, N
    FUJIWARA, T
    JEN, J
    KINZLER, KW
    WYLLIE, AH
    VOGELSTEN, B
    DUNLOP, MG
    [J]. NATURE MEDICINE, 1995, 1 (04) : 348 - 352
  • [8] Liu T, 2001, CANCER RES, V61, P7798
  • [9] A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States
    Lynch, HT
    Coronel, SM
    Okimoto, R
    Hampel, H
    Sweet, K
    Lynch, JF
    Barrows, A
    Wijnen, J
    van der Klift, H
    Franken, P
    Wagner, A
    Fodde, R
    de la Chapelle, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (06): : 718 - 724
  • [10] Genomic medicine - Hereditary colorectal cancer
    Lynch, HT
    de la Chapelle, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) : 919 - 932